These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12719721)

  • 1. Mouse models with modified p53 sequences to study cancer and ageing.
    Clarke AR; Hollstein M
    Cell Death Differ; 2003 Apr; 10(4):443-50. PubMed ID: 12719721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of p53 mutant mice.
    Dumble ML; Donehower LA; Lu X
    Methods Mol Biol; 2003; 234():29-49. PubMed ID: 12824523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into aging obtained from p53 mutant mouse models.
    Dumble M; Gatza C; Tyner S; Venkatachalam S; Donehower LA
    Ann N Y Acad Sci; 2004 Jun; 1019():171-7. PubMed ID: 15247009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complicating the role of p53 in aging.
    Gentry A; Venkatachalam S
    Aging Cell; 2005 Jun; 4(3):157-60. PubMed ID: 15924572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 alterations in human cancer: more questions than answers.
    Soussi T
    Oncogene; 2007 Apr; 26(15):2145-56. PubMed ID: 17401423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53-deficient mouse: a model for basic and applied cancer studies.
    Donehower LA
    Semin Cancer Biol; 1996 Oct; 7(5):269-78. PubMed ID: 9110404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When mutant p53 plays hide and seek: a new challenge for diagnosis and therapy?
    Soussi T; Hjortsberg L
    Trends Mol Med; 2009 Jan; 15(1):1-4. PubMed ID: 19097939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing p53 biological functions through the use of genetically engineered mouse models.
    Attardi LD; Donehower LA
    Mutat Res; 2005 Aug; 576(1-2):4-21. PubMed ID: 16038709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
    Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
    Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-aging activity of the Ink4/Arf locus.
    Matheu A; Maraver A; Collado M; Garcia-Cao I; Cañamero M; Borras C; Flores JM; Klatt P; Viña J; Serrano M
    Aging Cell; 2009 Apr; 8(2):152-61. PubMed ID: 19239418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed ageing through damage protection by the Arf/p53 pathway.
    Matheu A; Maraver A; Klatt P; Flores I; Garcia-Cao I; Borras C; Flores JM; Viña J; Blasco MA; Serrano M
    Nature; 2007 Jul; 448(7151):375-9. PubMed ID: 17637672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the p53 pathway.
    Pietsch EC; Humbey O; Murphy ME
    Oncogene; 2006 Mar; 25(11):1602-11. PubMed ID: 16550160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological ageing: role of p53 and PARP-1 tumor suppressors in the regulation of terminal senescence.
    Wesierska-Gadek J; Ranftler C; Schmid G
    J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():77-88. PubMed ID: 16077192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific p53 responses to ionizing radiation and their genetic modification: the key to tissue-specific tumour susceptibility?
    Coates PJ; Lorimore SA; Lindsay KJ; Wright EG
    J Pathol; 2003 Nov; 201(3):377-88. PubMed ID: 14595749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mouse with human mutant p53 expression in the prostate epithelium.
    Elgavish A; Wood PA; Pinkert CA; Eltoum IE; Cartee T; Wilbanks J; Mentor-Marcel R; Tian L; Scroggins SE
    Prostate; 2004 Sep; 61(1):26-34. PubMed ID: 15287091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging, p53 and the '24 gene mutant': getting it right. A reply to Vijg and Hasty.
    Venkatachalam S
    Aging Cell; 2005 Dec; 4(6):335-8. PubMed ID: 16300487
    [No Abstract]   [Full Text] [Related]  

  • 17. p53 mutant mice that display early ageing-associated phenotypes.
    Tyner SD; Venkatachalam S; Choi J; Jones S; Ghebranious N; Igelmann H; Lu X; Soron G; Cooper B; Brayton C; Park SH; Thompson T; Karsenty G; Bradley A; Donehower LA
    Nature; 2002 Jan; 415(6867):45-53. PubMed ID: 11780111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging and cancer cell biology, 2008.
    Campisi J
    Aging Cell; 2008 Jun; 7(3):281-4. PubMed ID: 18331618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic phasing of a mouse chromosome 11 deficiency influences p53 tumorigenicity.
    Biggs PJ; Vogel H; Sage M; Martin LA; Donehower LA; Bradley A
    Oncogene; 2003 May; 22(21):3288-96. PubMed ID: 12761499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age activator.
    Novak K
    Nat Rev Cancer; 2002 Feb; 2(2):81. PubMed ID: 12635170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.